跳至主要内容
临床试验/NCT00974610
NCT00974610已完成不适用

Collaborative Project on Potential Serum Markers for Malignant Melanoma, Metastatic Breast, Advanced Lung Pancreatic Carcinoma and Colorectal Cancer

Cancer Trials Ireland13 个研究点 分布在 1 个国家目标入组 803 人开始时间: 2008年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
803
试验地点
13
主要终点
Detection of peptide and protein markers in serum

研究概览

简要总结

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in peptides and proteins and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples from patients with malignant melanoma, metastatic breast cancer, advanced lung cancer, pancreatic cancer, or colorectal cancer.

详细描述

OBJECTIVES:

Primary

  • To assess which potential peptide and protein markers produced by human melanoma, lung, breast, pancreatic, and colorectal cell lines may be detectable in serum of patients from these five disease groups.

Secondary

  • To conduct further extensive investigation with respect to identification of the protein/peptide involved, determination of specificity for each cancer, and development of more sensitive assays to look for such markers in a wider population of patients, including those undergoing therapy.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Detection of peptide and protein markers in serum

时间窗: Ongoing

次要结局

  • Identification of the protein/peptide involved(Ongoing)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验

Study of Blood Samples From Patients With Malignant... | 临床试验